Allscripts announces fourth quarter and 2018 full-year results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Allscripts (MDRX) PT Lowered to $14 at Cowen
February 22, 2019 7:12 AM ESTCowen analyst Charles Rhyee lowered the price target on Allscripts (NASDAQ: MDRX) to $14.00 (from $16.00) while maintaining a Outperform rating following the company's 4Q. Adjusted EPS of $0.20 and revenues of $538M missed consensus of $0.21 and $563M, respectively, reflecting impact of weak 3Q bookings.
MDRX introduced... More
Allscripts (MDRX) Misses Q4 EPS by 1c, FY EPS Guidance Misses
February 21, 2019 4:16 PM ESTAllscripts (NASDAQ: MDRX) reported Q4 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $538 million versus the consensus estimate of $563.83 million.
GUIDANCE:
Allscripts sees FY2019 EPS of $0.65-$0.70, versus the consensus of $0.81.
First quarter 2019 non-GAAP revenue... More